Johnson and Johnson Innovative Medicine, United States
Disclosure information not submitted.
Comparing the performance of probabilistic and rule-based phenotype algorithms for angioedema to the experience observed in randomized clinical trials.
Monday, August 26, 20246:30 PM – 6:45 PM CEST
